Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Levonorgestrel transdermal system

Shulman LP, Yankov V, Uhl K. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women the results of two multicenter, double-blind, randomized, controlled trials. Menopause 2002 9(3) 195-207. [Pg.280]

Fig. 18 (Upper panel) The 4—week serum levonorgestrel profiles in 12 human volunteers, each receiving 1 or 2 units of a transdermal contraceptive system (10 cm, with daily dosage of 28.3 pg/day) once a week, consecutively for 3 weeks, and the same size of placebo on week 4. (Lower panel) Comparative serum concentration profiles of progesterone during the pretreatment and treatment cycles in two subjects, each as the representative for group A (receiving lOcm ) and group B (receiving 20 cm ), respectively. The suppression of progesterone peak during the treatment cycle is an indication of effective fertility control. Fig. 18 (Upper panel) The 4—week serum levonorgestrel profiles in 12 human volunteers, each receiving 1 or 2 units of a transdermal contraceptive system (10 cm, with daily dosage of 28.3 pg/day) once a week, consecutively for 3 weeks, and the same size of placebo on week 4. (Lower panel) Comparative serum concentration profiles of progesterone during the pretreatment and treatment cycles in two subjects, each as the representative for group A (receiving lOcm ) and group B (receiving 20 cm ), respectively. The suppression of progesterone peak during the treatment cycle is an indication of effective fertility control.
See other pages where Levonorgestrel transdermal system is mentioned: [Pg.257]    [Pg.257]    [Pg.257]    [Pg.1697]    [Pg.428]    [Pg.1087]    [Pg.236]    [Pg.119]   
See also in sourсe #XX -- [ Pg.225 ]



SEARCH



Transdermal

Transdermal systems

© 2024 chempedia.info